Paper6416699
Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).
Smith PH and 9 others. Cancer Chemother Pharmacol, 1983. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG). Papers, record 6416699. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6416699
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Cisplatin | |
| Clinical Trials as Topic | |
| Combined Modality Therapy | |
| Cyclophosphamide | |
| Doxorubicin | |
| Fluorouracil | |
| Follow-Up Studies | |
| Humans | |
| Mitomycin | |
| Mitomycins | |
| Multi-Institutional Systems | |
| Prognosis |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1101401 | The current status of bladder cancer. | Surg Annu | 1975 | https://conductscience.org/library/papers/1101401 | PubMed |
| 2 | 597707 | The treatment of advanced bladder cancer with methotrexate. | Br J Urol | 1977 | https://conductscience.org/library/papers/597707 | PubMed |
| 3 | 7194736 | Cyclophosphamide, doxorubicin, and cisplatin (CAP) in the treatment of urothelial malignancy: a pilot study of the Southeastern Cancer Study Group. | Cancer Treat Rep | 1981 | https://conductscience.org/library/papers/7194736 | PubMed |
| 4 | 1195468 | Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin. | J Urol | 1975 | https://conductscience.org/library/papers/1195468 | PubMed |
| 5 | 68814 | Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer. | Cancer Res | 1977 | https://conductscience.org/library/papers/68814 | PubMed |
| 6 | 324624 | Combination VM-26 and adriamycin for metastatic transitional cell carcinoma. | Cancer Treat Rep | 1977 | https://conductscience.org/library/papers/324624 | PubMed |
| 7 | 7379051 | Phase II study of 5-fluorouracil and adriamycin in transitional cell carcinoma of the urinary tract. | Cancer Treat Rep | 1980 | https://conductscience.org/library/papers/7379051 | PubMed |
| 8 | 913456 | The treatment of advanced carcinoma of the bladder with a combination of adriamycin and 5-fluorouracil. | Eur Urol | 1977 | https://conductscience.org/library/papers/913456 | PubMed |
| 9 | 7200890 | Cyclophosphamide, adriamycin and cisplatin combination chemotherapy in advanced bladder carcinoma: an EORTC phase II study. | Eur J Cancer Clin Oncol | 1982 | https://conductscience.org/library/papers/7200890 | PubMed |
| 10 | 7370989 | Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione. | Cancer Res | 1980 | https://conductscience.org/library/papers/7370989 | PubMed |
| 11 | 7061245 | Adjuvant chemotherapy and cancer cure. | Int J Radiat Oncol Biol Phys | 1982 | https://conductscience.org/library/papers/7061245 | PubMed |
| 12 | 628005 | Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones. | J Med Chem | 1978 | https://conductscience.org/library/papers/628005 | PubMed |
| 13 | 7044462 | Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. | Br J Urol | 1982 | https://conductscience.org/library/papers/7044462 | PubMed |
| 14 | 7194923 | The management of advanced bladder carcinoma. | J Urol | 1981 | https://conductscience.org/library/papers/7194923 | PubMed |
| 15 | 14346445 | THE EFFECT OF CYCLOPHOSPHAMIDE ON SOME URINARY TRACT TUMOURS. | Br J Urol | 1965 | https://conductscience.org/library/papers/14346445 | PubMed |
| 16 | 657084 | Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer. | Cancer | 1978 | https://conductscience.org/library/papers/657084 | PubMed |
| 17 | 7370937 | Current perspectives in the management of high-grade invasive bladder cancer. | Cancer | 1980 | https://conductscience.org/library/papers/7370937 | PubMed |
| 18 | 125624 | The chemotherapy of urologic cancer. | Cancer | 1975 | https://conductscience.org/library/papers/125624 | PubMed |
| 19 | 113879 | Current concepts in the management of patients with deeply invasive bladder carcinoma. | Semin Oncol | 1979 | https://conductscience.org/library/papers/113879 | PubMed |
| 20 | 6160912 | Combination chemotherapy with cyclophosphamide, doxorubicin, and bleomycin for metastatic transitional cell carcinoma of the urinary tract. | Cancer Treat Rep | 1980 | https://conductscience.org/library/papers/6160912 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 3664943 | The chemotherapy of advanced bladder cancer. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3664943 | PubMed |
| 3664942 | Postoperative systemic adjuvant chemotherapy for bladder cancer. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3664942 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6416699
GET https://conductscience.org/api/papers/v1/6416699/references?page=2